Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -0.30 (-0.44%)
Bid:
67.50
Ask:
67.70
Spread: 0.20 (0.296%)
Market Cap: £598.08m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Further re Scrip Dividend

29 Jun 2022 09:16

RNS Number : 6180Q
IP Group PLC
29 June 2022
 

FOR RELEASE ON

29 June 2022

 

IP Group plc - Further re Scrip Dividend

 

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces that further to the announcement made on 06 June 2022 in relation to the Scrip Dividend, the Group has received valid elections from certain shareholders. IP Group intends to sell Ordinary Shares which are currently held in treasury to satisfy such elections and will transfer these shares pursuant to the Scrip Dividend Terms and Conditions ("the Scrip Dividend Shares"). 

 

330,851 Scrip Dividend Shares will be transferred to relevant shareholders on 30 June 2022. Following such transfer, and in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Group will have 1,063,033,287 Ordinary Shares in issue and 28,607,622 shares in Treasury.

 

The total number of Ordinary Shares with voting rights following the satisfaction of the transfer will be 1,034,425,665 Ordinary Shares. This figure may be used by shareholders in the Group as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURMZGZVRLMGZZG
Date   Source Headline
18th Mar 20257:00 amRNSNotice of Results
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20256:11 pmRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20255:15 pmRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:48 amRNSPortfolio company Hinge Health files for IPO
10th Mar 20255:53 pmRNSTransaction in Own Shares
7th Mar 20255:16 pmRNSTransaction in Own Shares
7th Mar 20253:31 pmRNSHolding(s) in Company
6th Mar 20255:55 pmRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20256:26 pmRNSTransaction in Own Shares
3rd Mar 20255:51 pmRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTotal Voting Rights
28th Feb 20255:16 pmRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20256:09 pmRNSTransaction in Own Shares
24th Feb 20255:17 pmRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20256:14 pmRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSIstesso update on P2b study of leramistat in RA
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20255:36 pmRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20255:40 pmRNSTransaction in Own Shares
7th Feb 20255:48 pmRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20256:21 pmRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:01 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20255:59 pmRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20256:08 pmRNSTransaction in Own Shares
21st Jan 20256:21 pmRNSTransaction in Own Shares
20th Jan 20256:00 pmRNSTransaction in Own Shares
17th Jan 20256:17 pmRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20255:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.